4,757
Views
65
CrossRef citations to date
0
Altmetric
RESEARCH PAPERS

Propionic acid and butyric acid inhibit lipolysis and de novo lipogenesis and increase insulin-stimulated glucose uptake in primary rat adipocytes

, &
Pages 81-88 | Received 08 Apr 2014, Accepted 28 Aug 2014, Published online: 14 Nov 2014

References

  • DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010; 53:1270-87; PMID:20361178; http://dx.doi.org/10.1007/s00125-010-1684-1
  • Capurso C, Capurso A. From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol 2012; 57:91-7; PMID:22609131; http://dx.doi.org/10.1016/j.vph.2012.05.003
  • Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29:2959-71; PMID:18775919; http://dx.doi.org/10.1093/eurheartj/ehn387
  • Mittendorfer B. Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking. Curr Opin Clin Nutr Metab Care 2011; 14:535-41; PMID:21849896; http://dx.doi.org/10.1097/MCO.0b013e32834ad8b6
  • Henry SL, Bensley JG, Wood-Bradley RJ, Cullen-McEwen LA, Bertram JF, Armitage JA. White adipocytes: more than just fat depots. Int J BiochemCell Biol 2012; 44:435-40; PMID:22222895; http://dx.doi.org/10.1016/j.biocel.2011.12.011
  • Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Prac Res Clin Gastroenterol 2013; 27:73-83; PMID:23768554; http://dx.doi.org/10.1016/j.bpg.2013.03.007
  • Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophy Acta 2010; 1801:1175-83; PMID:20691280; http://dx.doi.org/10.1016/j.bbalip.2010.07.007
  • den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 2013; 54:2325-40; PMID:23821742; http://dx.doi.org/10.1194/jlr.R036012
  • Boillot J, Alamowitch C, Berger AM, Luo J, Bruzzo F, Bornet FR, Slama G. Effects of dietary propionate on hepatic glucose production, whole-body glucose utilization, carbohydrate and lipid metabolism in normal rats. Br J Nutr 1995; 73:241-51; PMID:7718543; http://dx.doi.org/10.1079/BJN19950026
  • Berggren AM, Nyman EM, Lundquist I, Bjorck IM. Influence of orally and rectally administered propionate on cholesterol and glucose metabolism in obese rats. Br J Nutr 1996; 76:287-94; PMID:8813902; http://dx.doi.org/10.1079/BJN19960032
  • Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009; 58:1509-17; PMID:19366864; http://dx.doi.org/10.2337/db08-1637
  • Yamashita H, Fujisawa K, Ito E, Idei S, Kawaguchi N, Kimoto M, Hiemori M, Tsuji H. Improvement of obesity and glucose tolerance by acetate in Type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Biosci Biotechnol Biochem 2007; 71:1236-43; PMID:17485860; http://dx.doi.org/10.1271/bbb.60668
  • Lin HV, Frassetto A, Kowalik EJ, Jr., Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PloS One 2012; 7:e35240; PMID:22506074; http://dx.doi.org/10.1371/journal.pone.0035240
  • Wolever TM, Spadafora P, Eshuis H. Interaction between colonic acetate and propionate in humans. Am J Clin Nutr 1991; 53:681-7; PMID:2000822
  • Todesco T, Rao AV, Bosello O, Jenkins DJ. Propionate lowers blood glucose and alters lipid metabolism in healthy subjects. Am J Clin Nutr 1991; 54:860-5; PMID:1951157
  • Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J J Biol Chem 2003; 278:11312-9; PMID:12496283; http://dx.doi.org/10.1074/jbc.M211609200
  • Hong YH, Nishimura Y, Hishikawa D, Tsuzuki H, Miyahara H, Gotoh C, Choi KC, Feng DD, Chen C, Lee HG, et al. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 2005; 146:5092-9; PMID:16123168; http://dx.doi.org/10.1210/en.2005-0545
  • Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL, Tian H, Li Y. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 2008; 149:4519-26; PMID:18499755; http://dx.doi.org/10.1210/en.2008-0059
  • Londos C, Brasaemle DL, Schultz CJ, Adler-Wailes DC, Levin DM, Kimmel AR, Rondinone CM. On the control of lipolysis in adipocytes. Ann N Y Acad Sci 1999; 892:155-68; PMID:10842661; http://dx.doi.org/10.1111/j.1749-6632.1999.tb07794.x
  • Castan I, Wijkander J, Manganiello V, Degerman E. Mechanisms of inhibition of lipolysis by insulin, vanadate and peroxovanadate in rat adipocytes. Biochem J 1999; 339 (Pt 2):281-9; PMID:10191258; http://dx.doi.org/10.1042/0264-6021:3390281
  • Czech MP, Tencerova M, Pedersen DJ, Aouadi M. Insulin signalling mechanisms for triacylglycerol storage. Diabetologia 2013; 56:949-64; PMID:23443243; http://dx.doi.org/10.1007/s00125-013-2869-1
  • Schreurs M, Kuipers F, van der Leij FR. Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome. Obes Rev 2010; 11:380-8; PMID:19694967; http://dx.doi.org/10.1111/j.1467-789X.2009.00642.x
  • Chaves VE, Frasson D, Kawashita NH. Several agents and pathways regulate lipolysis in adipocytes. Biochimie 2011; 93:1631-40; PMID:21658426; http://dx.doi.org/10.1016/j.biochi.2011.05.018
  • Zaibi MS, Stocker CJ, O'Dowd J, Davies A, Bellahcene M, Cawthorne MA, Brown AJ, Smith DM, Arch JR. Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett 2010; 584:2381-6; PMID:20399779; http://dx.doi.org/10.1016/j.febslet.2010.04.027
  • Aberdein N, Schweizer M, Ball D. Sodium acetate decreases phosphorylation of hormone sensitive lipase in isoproterenol-stimulated 3T3-L1 mature adipocytes. Adipocyte 2014; 3:121-5; PMID:24719785; http://dx.doi.org/10.4161/adip.27936
  • Nishina PM, Freedland RA. Effects of propionate on lipid biosynthesis in isolated rat hepatocytes. J Nutr 1990; 120:668-73; PMID:2366102
  • Demigne C, Morand C, Levrat MA, Besson C, Moundras C, Remesy C. Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br J Nutr 1995; 74:209-19; PMID:7547838; http://dx.doi.org/10.1079/BJN19950124
  • Ebeling P, Koistinen HA, Koivisto VA. Insulin-independent glucose transport regulates insulin sensitivity. FEBS Lett 1998; 436:301-3; PMID:9801136; http://dx.doi.org/10.1016/S0014-5793(98)01149-1
  • Munoz S, Franckhauser S, Elias I, Ferre T, Hidalgo A, Monteys AM, Molas M, Cerdan S, Pujol A, Ruberte J, et al. Chronically increased glucose uptake by adipose tissue leads to lactate production and improved insulin sensitivity rather than obesity in the mouse. Diabetologia 2010; 53:2417-30; PMID:20623219; http://dx.doi.org/10.1007/s00125-010-1840-7
  • Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001; 409:729-33; PMID:11217863; http://dx.doi.org/10.1038/35055575
  • Al-Lahham S, Roelofsen H, Rezaee F, Weening D, Hoek A, Vonk R, Venema K. Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects. Eur J Clin Invest 2012; 42:357-64; PMID:21913915; http://dx.doi.org/10.1111/j.1365-2362.2011.02590.x
  • Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, Tani T, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 2013; 4:1829; PMID:23652017; http://dx.doi.org/10.1038/ncomms2852
  • Wolever TM, Josse RG, Leiter LA, Chiasson JL. Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. Metabolism 1997; 46:805-11; PMID:9225836; http://dx.doi.org/10.1016/S0026-0495(97)90127-X
  • Bach Knudsen KE, Serena A, Canibe N, Juntunen KS. New insight into butyrate metabolism. Proc Nutr Soc 2003; 62:81-6; PMID:12740062; http://dx.doi.org/10.1079/PNS2002212
  • Nilsson AC, Ostman EM, Knudsen KE, Holst JJ, Bjorck IM. A cereal-based evening meal rich in indigestible carbohydrates increases plasma butyrate the next morning. J Nutr 2010; 140:1932-6; PMID:20810606; http://dx.doi.org/10.3945/jn.110.123604
  • Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc 2003; 62:67-72; PMID:12740060; http://dx.doi.org/10.1079/PNS2002207
  • Soldavini J, Kaunitz JD. Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity. Dig Dis Sci 2013; 58:2756-66; PMID:23839339; http://dx.doi.org/10.1007/s10620-013-2744-4
  • Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28:1221-7; PMID:3678950; http://dx.doi.org/10.1136/gut.28.10.1221
  • Jakobsdottir G, Bjerregaard JH, Skovbjerg H, Nyman M. Fasting serum concentration of short-chain fatty acids in subjects with microscopic colitis and celiac disease: no difference compared with controls, but between genders. Scand J Gastroenterol 2013; 48:696-701; PMID:23600961; http://dx.doi.org/10.3109/00365521.2013.786128
  • Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 2005; 82:559-67; PMID:16155268
  • Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat A, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 2011; 5:220-30; PMID:20686513; http://dx.doi.org/10.1038/ismej.2010.118
  • Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, Flint HJ. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) 2008; 32:1720-4; PMID:18779823; http://dx.doi.org/10.1038/ijo.2008.155
  • Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444:1022-3; PMID:17183309; http://dx.doi.org/10.1038/4441022a
  • Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, Hardt PD. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010; 18:190-5; PMID:19498350; http://dx.doi.org/10.1038/oby.2009.167
  • Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490:55-60; PMID:23023125; http://dx.doi.org/10.1038/nature11450
  • Vrieze A, Van Nood E, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143:913-6. e7; PMID:22728514; http://dx.doi.org/10.1053/j.gastro.2012.06.031
  • Honnor RC, Dhillon GS, Londos C. cAMP-dependent protein kinase and lipolysis in rat adipocytes. I. Cell preparation, manipulation, and predictability in behavior. J Biol Chem 1985; 260:15122-9; PMID:2415513
  • Fine JB, DiGirolamo M. A simple method to predict cellular density in adipocyte metabolic incubations. Int J Obes Relat Metab Disd 1997; 21:764-8; PMID:9376888; http://dx.doi.org/10.1038/sj.ijo.0800469
  • Dole VP, Meinertz H. Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem 1960; 235:2595-9; PMID:13817286
  • Moody AJ, Stan MA, Stan M, Gliemann J. A simple free fat cell bioassay for insulin. Horm Metab Res 1974; 6:12-6; PMID:4819286; http://dx.doi.org/10.1055/s-0028-1093895
  • Foley JE, Kashiwagi A, Verso MA, Reaven G, Andrews J. Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics. Measurements of glucose transport and metabolism, insulin binding, and lipolysis in isolated adipocytes. J Clin Invest 1983; 72:1901-9; PMID:6358258; http://dx.doi.org/10.1172/JCI111153